(Q41540554)

2 October 2017

title

Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates (English)

1 reference

2 October 2017

A J Rowland

1

1 reference

2 October 2017

G A Pietersz

series ordinal

2

1 reference

2 October 2017

I F McKenzie

series ordinal

3

1 reference

2 October 2017

publication date

1 August 1993

1 reference

Cancer Immunology, Immunotherapy

2 October 2017

published in

1 reference

2 October 2017

volume

37

1 reference

2 October 2017

issue

3

1 reference

2 October 2017

page(s)

195-202

1 reference

Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose

2 October 2017

cites work

1 reference

12 December 2020

Phase I study of 4-demethoxydaunorubicin

1 reference

12 December 2020

Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins

1 reference

12 December 2020

Preclinical trials with combinations and conjugates of T101 monoclonal antibody and doxorubicin

1 reference

12 December 2020

The surface antigens of human B lymphocytes

1 reference

12 December 2020

Antitumor activity of idarubicin-monoclonal antibody conjugates in a disseminated thymic lymphoma model

1 reference

12 December 2020

CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA.

1 reference

12 December 2020

Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies.

1 reference

12 December 2020

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

1 reference

12 December 2020

Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody

1 reference

12 December 2020

The toxicity of chemically deglycosylated ricin A-chain in mice

1 reference

12 December 2020

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

1 reference

12 December 2020

Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas

1 reference

12 December 2020

Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution

1 reference

12 December 2020

Preparation and characterization of a chimeric CD 19 monoclonal antibody

1 reference

12 December 2020

Phase I immunotoxin trial in patients with B-cell lymphoma

1 reference

12 December 2020

Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy

1 reference

12 December 2020

Production of monoclonal antibodies to serum antigens in colorectal carcinoma

1 reference

12 December 2020

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

1 reference

12 December 2020

Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations

1 reference

12 December 2020

Tumor localization by combinations of monoclonal antibodies in a new human colon carcinoma cell line (LIM1899).

1 reference

12 December 2020

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing

1 reference

12 December 2020

Antibody conjugates for the treatment of cancer

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6.

1 reference

12 December 2020

Immunochemotherapy of a murine thymoma with the use of idarubicin monoclonal antibody conjugates

1 reference

12 December 2020

Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma

1 reference

12 December 2020

Immunotoxins: a clinical review of their use in the treatment of malignancies

1 reference

12 December 2020

Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies

1 reference

12 December 2020

A clinical trial of anti-idiotype therapy for B cell malignancy

1 reference

12 December 2020

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

1 reference

12 December 2020

Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies

1 reference

12 December 2020

Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors

1 reference

12 December 2020

Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies

1 reference

12 December 2020

An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01525435

1 reference

Dimensions Publication ID

2 October 2017

1015981606

0 references

Fatcat ID

release_wi3s7xn35jg2fmovaxbytnwrxu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wi3s7xn35jg2fmovaxbytnwrxu

24 November 2022

mapped directly with Wikidata item

1 reference